ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 56 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $10 | 0.0% | 14,498 | -15.6% | 0.00% | 0.0% |
| Q4 2022 | $10 | -100.0% | 17,174 | -76.8% | 0.00% | -96.0% |
| Q2 2021 | $259,000 | +15.6% | 73,955 | +257.9% | 0.02% | +4.2% |
| Q4 2020 | $224,000 | -33.1% | 20,665 | -36.5% | 0.02% | -57.9% |
| Q3 2020 | $335,000 | -40.4% | 32,527 | +20.8% | 0.06% | -12.3% |
| Q2 2020 | $562,000 | +473.5% | 26,924 | +49.9% | 0.06% | +712.5% |
| Q3 2019 | $98,000 | +48.5% | 17,964 | -13.9% | 0.01% | +100.0% |
| Q4 2018 | $66,000 | -43.6% | 20,862 | +3.7% | 0.00% | -33.3% |
| Q1 2018 | $117,000 | +120.8% | 20,123 | +38.1% | 0.01% | +100.0% |
| Q3 2017 | $53,000 | – | 14,575 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
| Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
| Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
| COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
| VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
| AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
| Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
| Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
| Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
| Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |